These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 32592703)

  • 1. Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study.
    Cantini F; Niccoli L; Nannini C; Matarrese D; Natale MED; Lotti P; Aquilini D; Landini G; Cimolato B; Pietro MAD; Trezzi M; Stobbione P; Frausini G; Navarra A; Nicastri E; Sotgiu G; Goletti D
    J Infect; 2020 Oct; 81(4):647-679. PubMed ID: 32592703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Baricitinib in the treatment of SARS-CoV-2 infection].
    Gutiérrez-Lorenzo M; Cuadros-Martínez CM
    Rev Esp Quimioter; 2020 Aug; 33(4):294-295. PubMed ID: 32583654
    [No Abstract]   [Full Text] [Related]  

  • 3. Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact.
    Cantini F; Niccoli L; Matarrese D; Nicastri E; Stobbione P; Goletti D
    J Infect; 2020 Aug; 81(2):318-356. PubMed ID: 32333918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baricitinib for COVID-19: a suitable treatment?
    Favalli EG; Biggioggero M; Maioli G; Caporali R
    Lancet Infect Dis; 2020 Sep; 20(9):1012-1013. PubMed ID: 32251638
    [No Abstract]   [Full Text] [Related]  

  • 5. Baricitinib for COVID-19: a suitable treatment? - Authors' reply.
    Richardson PJ; Corbellino M; Stebbing J
    Lancet Infect Dis; 2020 Sep; 20(9):1013-1014. PubMed ID: 32251639
    [No Abstract]   [Full Text] [Related]  

  • 6. Baricitinib, JAK inhibitors and liver injury: a cause for concern in COVID-19?
    Raschi E; Caraceni P; Poluzzi E; De Ponti F
    Expert Opin Drug Saf; 2020 Oct; 19(10):1367-1369. PubMed ID: 32840116
    [No Abstract]   [Full Text] [Related]  

  • 7. Mesenchymal stem cell therapy in severe COVID-19: A retrospective study of short-term treatment efficacy and side effects.
    Chen X; Shan Y; Wen Y; Sun J; Du H
    J Infect; 2020 Oct; 81(4):647-679. PubMed ID: 32422152
    [No Abstract]   [Full Text] [Related]  

  • 8. Can artificial intelligence identify effective COVID-19 therapies?
    Schultz MB; Vera D; Sinclair DA
    EMBO Mol Med; 2020 Aug; 12(8):e12817. PubMed ID: 32569446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease.
    Richardson P; Griffin I; Tucker C; Smith D; Oechsle O; Phelan A; Rawling M; Savory E; Stebbing J
    Lancet; 2020 Feb; 395(10223):e30-e31. PubMed ID: 32032529
    [No Abstract]   [Full Text] [Related]  

  • 10. Tele-rounding in a university hospital pulmonary ward during the COVID-19 pandemic: a pilot study.
    Renner A; Paajanen J; Reijula J
    Infect Dis (Lond); 2020 Sep; 52(9):669-670. PubMed ID: 32516031
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.
    Stebbing J; Krishnan V; de Bono S; Ottaviani S; Casalini G; Richardson PJ; Monteil V; Lauschke VM; Mirazimi A; Youhanna S; Tan YJ; Baldanti F; Sarasini A; Terres JAR; Nickoloff BJ; Higgs RE; Rocha G; Byers NL; Schlichting DE; Nirula A; Cardoso A; Corbellino M;
    EMBO Mol Med; 2020 Aug; 12(8):e12697. PubMed ID: 32473600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
    Seif F; Aazami H; Khoshmirsafa M; Kamali M; Mohsenzadegan M; Pornour M; Mansouri D
    Int Arch Allergy Immunol; 2020; 181(6):467-475. PubMed ID: 32392562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19.
    Praveen D; Puvvada RC; M VA
    Int J Antimicrob Agents; 2020 May; 55(5):105967. PubMed ID: 32259575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot virtual clerkship curriculum during the COVID-19 pandemic: Podcasts, peers and problem-solving.
    Geha R; Dhaliwal G
    Med Educ; 2020 Sep; 54(9):855-856. PubMed ID: 32418290
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre study.
    Pallotto C; Suardi LR; Esperti S; Tarquini R; Grifoni E; Meini S; Valoriani A; Di Martino S; Cei F; Sisti E; Piani F; Botta A; Salomoni E; Baragli F; Blanc P
    Infect Dis (Lond); 2020 Sep; 52(9):675-677. PubMed ID: 32543971
    [No Abstract]   [Full Text] [Related]  

  • 16. The Impact of COVID-19 on Italy: A Lesson for the Future.
    Santacroce L; Bottalico L; Charitos IA
    Int J Occup Environ Med; 2020 Jul; 11(3):151-152. PubMed ID: 32225178
    [No Abstract]   [Full Text] [Related]  

  • 17. An international, multicentre survey of echocardiographic abnormalities in COVID-19 patients.
    Ng ACT; Delgado V; Bax JJ
    Eur Heart J Cardiovasc Imaging; 2020 Sep; 21(9):959-960. PubMed ID: 32729899
    [No Abstract]   [Full Text] [Related]  

  • 18. [COVID-19-never waste a crisis?!].
    Herold CJ; Delorme S; Weber MA; Reith W; Helmberger T; Reiser M
    Radiologe; 2020 Oct; 60(10):891-892. PubMed ID: 32995967
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of SARS-CoV-2 in the female reproductive tract of COVID-19 patients: A prospective study.
    Hu YY; Ji DP; Yu YY; Li YJ; Li B; Hou GH; Zhang XD; Duan CC; Hu RB; Xu J
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1885-1888. PubMed ID: 33108863
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential implications of novel coronavirus disease (COVID-19) related gastrointestinal symptoms for abdominal imaging.
    Wilson MP; Katlariwala P; Low G
    Radiography (Lond); 2020 Aug; 26(3):274. PubMed ID: 32387085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.